JPMorgan Upgrades AstraZeneca (AZN) to Neutral
Get Alerts AZN Hot Sheet
Price: $67.75 -0.75%
Rating Summary:
17 Buy, 8 Hold, 3 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
17 Buy, 8 Hold, 3 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
JPMorgan upgraded AstraZeneca (NYSE: AZN) from Underweight to Neutral.
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $43.55 yesterday.
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $43.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- HSBC Upgrades Scor SE (SCR:FP) (SCRYY) to Buy, 'cheapest way to play the positive dynamics in reinsurance'
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!